1. Home
  2. NRSN vs BCG Comparison

NRSN vs BCG Comparison

Compare NRSN & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.59

Market Cap

26.3M

Sector

Health Care

ML Signal

HOLD

BCG

Binah Capital Group Inc.

HOLD

Current Price

$1.36

Market Cap

25.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRSN
BCG
Founded
2017
2016
Country
Israel
United States
Employees
16
150
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
25.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NRSN
BCG
Price
$0.59
$1.36
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
164.2K
16.0K
Earning Date
03-31-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$583.67
N/A
P/E Ratio
N/A
$56.15
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$1.36
52 Week High
$2.09
$3.44

Technical Indicators

Market Signals
Indicator
NRSN
BCG
Relative Strength Index (RSI) 25.73 37.48
Support Level N/A $1.36
Resistance Level $0.74 $1.61
Average True Range (ATR) 0.05 0.07
MACD -0.01 -0.01
Stochastic Oscillator 4.67 18.00

Price Performance

Historical Comparison
NRSN
BCG

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About BCG Binah Capital Group Inc.

Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.

Share on Social Networks: